These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34188210)

  • 41. New Diagnostic and Therapeutic Aspects of Pancreatic Ductal Adenocarcinoma.
    Mangge H; Niedrist T; Renner W; Lyer S; Alexiou C; Haybaeck J
    Curr Med Chem; 2017; 24(28):3012-3024. PubMed ID: 28494747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.
    Hidalgo M; Von Hoff DD
    Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contemporary Management of Pancreatic Cancer from an Internist Perspective.
    Sipra QUAR; Islam M; Riaz IB; Zhaohui J; Babiker HM; Bekaii-Saab TS; Sonbol MB
    Am J Med; 2021 May; 134(5):576-586. PubMed ID: 33316248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pancreatic cancer in a patient with myasthenia gravis.
    Patti R; Natalè E; Maringhini A
    Dig Dis Sci; 2004 Jun; 49(6):990-1. PubMed ID: 15309888
    [No Abstract]   [Full Text] [Related]  

  • 45. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
    Partensky C
    Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts.
    Scheiman JM; Hwang JH; Moayyedi P
    Gastroenterology; 2015 Apr; 148(4):824-48.e22. PubMed ID: 25805376
    [No Abstract]   [Full Text] [Related]  

  • 47. Pancreatic Cancer Early Detection and Interception in an Atypical Case of Peutz-Jeghers Syndrome.
    Mork M; Quesada PR; Bannon S; Montiel MF; Fleming JB; Lynch PM; Bhutani MS; Lee JH; McAllister F
    Pancreas; 2019 Apr; 48(4):e29-e30. PubMed ID: 30973470
    [No Abstract]   [Full Text] [Related]  

  • 48. Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?
    Liu DSK; Mato Prado M; Giovannetti E; Jiao LR; Krell J; Frampton AE
    Expert Rev Mol Diagn; 2019 Jul; 19(7):553-558. PubMed ID: 31159604
    [No Abstract]   [Full Text] [Related]  

  • 49. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
    Singh P; Srinivasan R; Wig JD
    Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Rare forms of the ductal carcinoma of the pancreas].
    Setdikova GR; Filippova EM; Paklina OV; Kriger AG; Chekmareva IA; Gorin DS; Berelavichus SV; Bedin VV; Tavobilov MM
    Khirurgiia (Mosk); 2013; (6):4-7. PubMed ID: 23887254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer.
    Buscail L; Bournet B; Cordelier P
    Nat Rev Gastroenterol Hepatol; 2020 Mar; 17(3):153-168. PubMed ID: 32005945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines.
    Alhamdani MS; Youns M; Buchholz M; Gress TM; Beckers MC; Maréchal D; Bauer A; Schröder C; Hoheisel JD
    J Proteomics; 2012 Jun; 75(12):3747-59. PubMed ID: 22579748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
    Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma.
    Lim KH; Langley E; Gao F; Luo J; Li L; Meyer G; Kim P; Singh S; Kushnir VM; Early DS; Mullady DK; Edmundowicz SA; Wani S; Murad FM; Cao D; Azar RR; Wang-Gillam A
    Oncotarget; 2017 Apr; 8(15):24250-24261. PubMed ID: 28445954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ICGC-ARGO precision medicine: familial matters in pancreatic cancer.
    Milella M; Luchini C; Lawlor RT; Johns AL; Casolino R; Yoshino T; Biankin AV;
    Lancet Oncol; 2022 Jan; 23(1):25-26. PubMed ID: 34973218
    [No Abstract]   [Full Text] [Related]  

  • 56. Signaling Networks That Control Cellular Plasticity in Pancreatic Tumorigenesis, Progression, and Metastasis.
    Crawford HC; Pasca di Magliano M; Banerjee S
    Gastroenterology; 2019 May; 156(7):2073-2084. PubMed ID: 30716326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pancreatic cancer and cancer screening programs: from nihilism to hope.
    Pezzilli R; Corinaldesi R; Morselli-Labate AM
    JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical decision making in the management of pancreatic cystic neoplasms.
    Atiq M; Suzuki R; Khan AS; Krishna SG; Ridgway TM; Guha S; Hernandez LV; Nealon WH; Lee JH; Bhutani MS
    Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):353-60. PubMed ID: 23639093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts.
    Vege SS; Ziring B; Jain R; Moayyedi P; ;
    Gastroenterology; 2015 Apr; 148(4):819-22; quize12-3. PubMed ID: 25805375
    [No Abstract]   [Full Text] [Related]  

  • 60. IER3 in pancreatic carcinogenesis.
    Molejon MI; Iovanna JL
    Oncotarget; 2015 Jun; 6(18):15712-3. PubMed ID: 26158545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.